2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons

Circulation (Impact Factor: 14.43). 11/2012; 126(25). DOI: 10.1161/CIR.0b013e318277d6a0
Source: PubMed
Download full-text


Available from: Joseph F Sabik, Sep 22, 2015
  • Source
    • "Arterial hypertension (AHT) was defined after two measurements (auscultatory sphygmomanometer; 5 mmHg error) if systolic pressure ≥ 140 mmHg, or diastolic pressure ≥ 90 mmHg, or if the patient was on blood pressure lowering therapy [26]. Ischemic heart disease (IHD) was defined on electrocardiographic criteria or on a history of acute coronary syndromes, stable angina, conduction and rhythm disturbances, and ischemic heart failure [27]. The recorded antiplatelet agents were aspirin and clopidogrel. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Atherosclerosis and osteoporosis share an age-independent bidirectional correlation.[1] Rheumatoid arthritis (RA) represents a risk factor for both conditions. So far, only hip and lumbar spine indices were used in clinical studies.[2] Objectives The study aims to evaluate the connection between the estimated cardiovascular risk (CVR) and the loss of whole body bone tissue in RA patients. Methods Prospective cross-sectional design; female in-patients with RA or without autoimmune diseases; bone tissue was measured using whole body dual X-ray absorptiometry (wbDXA); CVR was estimated using SCORE charts and PROCAM applications. Results There were 75 RA women and 66 normal women of similar age. The wbDXA bone indices correlate significantly, negatively and age-independently with the estimated CVR. The whole body bone percent (wbBP) was a significant predictor of estimated CVR, explaining 26% of SCORE variation along with low density lipoprotein (p<0.001) and 49.7% of PROCAM variation along with glycemia and menopause duration (p<0.001). Although obese patients had less bone relative to body composition (wbBP), in terms of absolute quantity their bone content was significantly higher than that of non-obese patients (p<0.001). Conclusions Female patients with RA and female patients with cardiovascular morbidity have a lower whole body bone percent. Obese female individuals have higher whole body bone mass than non-obese patients. The study suggests a common pathogenic process involving whole body bone tissue and atherosclerosis. References Disclosure of Interest None declared DOI 10.1136/annrheumdis-2014-eular.3671
    Full-text · Article · Jun 2014 · Journal of Osteoporosis
  • Source
    • "Just as for patients without diabetes, the best criterion for decision MR in patients with diabetes is the clinical assessment, considering the presence of myocardial ischemia (symptoms or evidence of complementary tests), evaluation of coronary anatomy and left ventricular systolic function. Indications for MR in patients with diabetes are similar to those for patients without diabetes, respecting the existing guidelines[75-77]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: There is a very well known correlation between diabetes and cardiovascular disease but many health care professionals are just concerned with glycemic control, ignoring the paramount importance of controlling other risk factors involved in the pathogenesis of serious cardiovascular diseases. This Position Statement from the Brazilian Diabetes Society was developed to promote increased awareness in relation to six crucial topics dealing with diabetes and cardiovascular disease: Glicemic Control, Cardiovascular Risk Stratification and Screening Coronary Artery Disease, Treatment of Dyslipidemia, Hypertension, Antiplatelet Therapy and Myocardial Revascularization. The issue of what would be the best algorithm for the use of statins in diabetic patients received a special attention and a new Brazilian algorithm was developed by our editorial committee. This document contains 38 recommendations which were classified by their levels of evidence (A, B, C and D). The Editorial Committee included 22 specialists with recognized expertise in diabetes and cardiology.
    Full-text · Article · May 2014 · Diabetology and Metabolic Syndrome
  • Source
    • "The first step towards a successful treatment outcome for the patient with CSA is an effective evaluation of anginal severity and its impact on patient functional status and QoL [4]. The purpose of this paper is to raise awareness of the prevalence of CSA, its impact on QoL, and the need for taking an accurate and thorough patient history when assessing patients with probable CSA. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Chronic stable angina (CSA) is a significant problem in the United States that can negatively impact patient quality of life (QoL). An accurate assessment of the severity of a patient's angina, the impact on their functional status, and their risk of cardiovascular complications is key to successful treatment of CSA. Active communication between the patient and their healthcare provider is necessary to ensure that patients receive optimal therapy. Healthcare providers should be aware of atypical symptoms of CSA in their patients, as patients may continue to suffer from angina despite the availability of multiple therapies. Patient questionnaires and symptom checklists can help patients communicate proactively with their healthcare providers. This paper discusses the prevalence of CSA, its impact on QoL, and the tools that healthcare providers can use to assess the severity of their patients' angina and the impact on QoL.
    Full-text · Article · Dec 2013
Show more